Abstract:Summary Objectives The primary objective of this study is to investigate if false vocal folds (FVF) or simultaneous FVF with thyroarytenoid (FVF + TA) Botox® injections achieve comparable treatment effects to standard TA injections. This study also aims to determine how patient-reported outcomes contribute to the transition to, and continuation of, FVF or FVF + TA injections. Methods Retrospective chart review was performed for all patients receiving Botox® for adductor spasmodic dysphonia at a laryngology practice between 2005 and 2018. Twenty out of 103 patients met the study's inclusion criteria. All subjects began standard treatment with TA injections. Based on response to injection, patients either continued to receive TA injections (group TA; n = 7), switched to FVF injections (group FVF; n = 7), or switched to FVF + TA injections (group FVF + TA; n = 6). A comparison of group means before and after initiation of FVF ± TA injections was performed between groups FVF and FVF + TA to group TA for the injection dosage, the duration of injection cycles, the patient-reported duration of best voice, and the presence and duration of breathiness and choking. Within-group observations were also compared before and after FVF ± TA injections. Results There were no significant findings for the variables between group FVF and group TA before FVF injections. The duration of injection cycles was significantly shorter for group FVF than group TA after FVF injections (95% CI: − 66.05, − 0.34; P = 0.05). However, duration of best voice quality, breathiness, and choking were similar ( P > 0.05) for group FVF to group TA after FVF injections. Group FVF + TA had a significantly shorter duration of injection cycles (95% CI: − 66.97, − 3.22; P = 0.03), best voice (95% CI: − 0.76, − 0.03; P = 0.04), and choking (95% CI: − 2.68, 0.02; P = 0.05) than group TA before FVF + TA injections. Group FVF + TA displayed a similar duration ( P > 0.05) of injection cycles, best voice quality, breathiness, and choking to group TA after FVF + TA injections. Within-group, increased duration of injection cycles and best voice were observed after FVF ± TA injections for both group FVF and FVF + TA. Acute adverse events were variable within groups after FVF ± TA injections. Conclusion This study compared outcomes of FVF or FVF + TA injections to successive TA injections among patients. FVF injections displayed similar duration of best voice quality, breathiness, and choking to TA injections. FVF + TA injections achieved similar duration of injection cycles, best voice quality, breathiness, and choking to TA injections. This study demonstrates that patients guided by a reduced duration of adverse events, while tolerating a shorter injection cycle, may benefit from initiation and continuation of FVF injections. Patients guided by increased duration of injection cycle and best voice, while tolerating the duration of adverse events, may benefit from initiation and continuation of FVF + TA injections.

Additional injection laryngoplasty as a salvage treatment for unilateral vocal fold paralysis

Long-Lasting Effect after Single Hyaluronate Injection for Unilateral Vocal Fold Paralysis: Does Concentration Matter?

Early injection laryngoplasty for acute unilateral vocal fold paralysis after thoracic aortic surgery

Hyaluronic Acid Injection Laryngoplasty for Unilateral Vocal Fold Paralysis—A Systematic Review and Meta-Analysis

The Long Term Results of Hyaluronic Acid/Dextranomer Injection Laryngoplasty in Unilateral Vocal Fold Paralysis

Office-Based Structural Autologous Fat Injection Laryngoplasty for Unilateral Vocal Fold Paralysis

Vocal fold medialization-A 5-year series of single surgeon consecutive medialization with review of literature

Comparison of the Effectiveness of Injection Laryngoplasty Using Autologous Platelet-Rich Plasma or Autologous Fat With Platelet-Rich Fibrin for the Treatment of Patients With Unilateral Vocal Fold Paralysis

Combination of Autologous Fascia Lata and Fat Injection into the Vocal Fold Via the Cricothyroid Gap for Unilateral Vocal Fold Paralysis

Injection Laryngoplasty of Unilateral Vocal Fold Paralysis Evaluated With Pause and Speech Measurements

Silk-Hyaluronic Acid for Vocal Fold Augmentation: Safety Profile and Long-Term Voice Outcomes

Indication and efficacy of injection laryngoplasty for laryngeal clefts - A retrospective cohort study

Predictors of injection laryngoplasty volume for glottic insufficiency

Patient-Reported Outcomes after False Vocal Folds Injections for Adductor Spasmodic Dysphonia

[Long-Term Follow-Up of Autogenous Fat Injection for Unilateral Vocal Cord Paralysis].

Factors Associated With Improvement Following In‐office Steroid Injections for Vocal Fold Scar

Preliminary report of vocal fold augmentation with cross-linked porcine collagen

The use of injectable calcium hydroxylapatite in the surgically pretreated larynx with glottal insufficiency

Platelet Rich Plasma (PRP) Treatment in Recalcitrant, Bilateral Phono-traumatic Lesions

Outcomes of Esophageal Cancer after Esophagectomy in the Era of Early Injection Laryngoplasty

Effect of a Single Injection of Basic Fibroblast Growth Factor into the Vocal Folds: A 36-Month Clinical Study